Article references (24 references )


  1. ONUSIDA. Rapport sur l'épidémie mondiale de sida. 2013: 4-6. Google Scholar

  2. Pilly E. Maladies Infectieuses et tropicales - 23e édition. 201 Collège des universitaires de Maladies Infectieuses et Tropicales (CMIT). Google Scholar

  3. Yeni P et al. Prise en charge médicale des personnes infectées par le VIH en France. Rapport 2010: 7 La documentation Française. Google Scholar

  4. Marziali M, Fimiani C, De Santis W, Isgrò A, Carello R, Leti W et al. T cell homeostasis alteration in HIV-1-infected subjects immunological non-responders to HAART. AIDS 2006 - XVI International AIDS Conference, abstract no. TUPE0004. Google Scholar

  5. Marimoutou C, Chêne G, Mercié P, Neau D, Farbos S et al. Prognostic Factors of Combined Viral Load and CD4+ Cell Count Responses under Triple Antiretroviral Therapy, Aquitaine Cohort, 1996-1998. J Acquir Immune Defic Syndr. 2001; 27(2): 161-167. PubMed | Google Scholar

  6. Grabar S, Le Moing V, Goulard C, Leport C et al. Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy. Ann Inter Med. 2000; 133 (6): 401-410. PubMed | Google Scholar

  7. Tan R, Westfall AO, Willig JH, Mugavero MJ, Saag MS, Kaslow RA, Kempf MC. Clinical outcome of HIV-infected antiretroviral-naive patients with discordant immunologic and virologic responses to highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2008; 47(5): 553-558. PubMed | Google Scholar

  8. Moore DM, Hogg RS, Yip B, Wood E, Tyndall M, Braitstein P, Montaner JS. Discordant immunologic and virologic responses to highly active antiretroviral therapy are associated with increased mortality and poor adherence. J Acquir Immune Defic Syndr. 2005; 40(3): 288-293. PubMed | Google Scholar

  9. Lima VD, Harrigan R, Murray M, Moore DM, Wood E, Hogg RS, Montaner JS. Differential impact of adherence on long-term treatment response among naive HIV-1 infected individuals. AIDS. 2008; 22(17): 2371-2380. PubMed | Google Scholar

  10. Anude CJ, Eze E, Onyegbutulem HC, Charurat M, Etiebet MA, Ajayi S et al. Immuno-virologic outcomes and immuno-virologic discordance among adults alive and on anti-retroviral therapy at 12 months in Nigeria. BMC Infect Dis. 2013; 13: 113. PubMed | Google Scholar

  11. Manga NM, Cisse-Diallo VMP, Lakhe NA, Ndongue-Sarr M, Batista G, Ngom-Guéye NF et al. Etude comparative des PVVIH sous trithérapie avec une restauration immunitaire optimale et cas de dissociation immunovirologique; Abstract. JNI 2013 ; 14es édition ; Clermont-Ferrand ; France. Google Scholar

  12. Kelley CF, Kitchen CMR, Hunt PW et al. Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment. Clin Inf Dis. 2009; 48(6): 787-794. PubMed | Google Scholar

  13. Bashi J, Balestre E, Messou E, Maiga M, Coffie PM, Zannou DM et al. Évolution des conditions d'initiation du traitement antirétroviral des patients infectés par le VIH en Afrique de l'Ouest. Méd Mal Inf. 2010; 40(8): 449-455. PubMed | Google Scholar

  14. Giordano TP, Wright JA, Hasan MQ, White AC Jr, Graviss EA, Visnegarwala F. Do Sex and Race/Ethnicity Influence CD4 Cell Response in Patients Who Achieve Virologic Suppression during Antiretroviral Therapy. HIV/AIDS-CID. 2003; 37: 433-437. PubMed | Google Scholar

  15. The Antiretroviral therapy Cohort Collaboration (ART-CC). HIV treatment response and prognosis in Europe and Nord America in the first decade of highly active antiretroviral therapy: a collaborative analysis. Lancet. 2006; 368(9534): 451-458. PubMed | Google Scholar

  16. Viard JP, Mocroft A, Chiesi A et al. Influence of age on CD4 cell recovery in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA study. J Inf Dis. 2001; 183(8): 1290-1294. PubMed | Google Scholar

  17. Pinzone MR, Di Rosa M, Cacopardo B, Nunnari G. HIV RNA Suppression and Immune Restoration: Can We Do Better? Clin Dev Imm. 2012; 515962: 12 pages. PubMed | Google Scholar

  18. Zannou DM, Kindé-Gazard D, Vigan J, Adè G, Sèhonou JJ, Atadokpèdé F et al. Profil clinique et immunologique des patients infectés par le VIH dépistés à Cotonou, Bénin. Méd Mal Inf. 2004; 34: 225-228. PubMed | Google Scholar

  19. Mouhari-Toure A, Patassi A, Nabroulala KT, Djadou KE, Edou K, Nyametso D et al. Profil biologique des patients adultes infectés par le VIH à l'initiation du traitement antirétroviral au Togo. Med Mal Inf. 2011; 41: 229-234. PubMed | Google Scholar

  20. Castetbon K, Malvy D. Dénutrition chez les patients infectés par le virus de l'immunodéficience humaine. Nutr Clin Métabol. 1999; 13: 17-24. PubMed | Google Scholar

  21. Rakotoarimanana R. Nutrition et infection. Rev Med Suisse. 2009; 5: 1975-1978. PubMed | Google Scholar

  22. Girard PM, Katlama C, Pialoux G. VIH. Edition 2011: le nouveau doin est arrivé. Google Scholar

  23. Kaufmann GR, Perrin L, Pantaleo G et al. CD4 T lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV cohort Study. Arch Intern Med. 2003; 163(18): 2187-2195. PubMed | Google Scholar

  24. Smith CJ, Sabin CA, Youle MS et al. Factors influencing increases in CD4 cell counts of HIV-positive persons receiving long-term highly active antiretroviral therapy. J Inf Dis. 2004; 190(10): 1860-1868. PubMed | Google Scholar